This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010:49:1-36.

doi: 10.1016/S0079-6468(10)49001-3.

The Journey to the Discovery of Boceprevir: an NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis C

Kevin X Chen¹, F George Njoroge

Affiliations

PMID: 20855037
DOI: 10.1016/S0079-6468(10)49001-3

Review

The Journey to the Discovery of Boceprevir: an NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis C

Kevin X Chen et al. Prog Med Chem. 2010.

. 2010:49:1-36.

doi: 10.1016/S0079-6468(10)49001-3.

Authors

Kevin X Chen¹, F George Njoroge

Affiliation

¹ Merek Research Laboratories, Kenilworth, NJ 07033, USA.

PMID: 20855037
DOI: 10.1016/S0079-6468(10)49001-3

No abstract available

PubMed Disclaimer

Similar articles

Boceprevir, an NS3 protease inhibitor of HCV.
Berman K, Kwo PY. Berman K, et al. Clin Liver Dis. 2009 Aug;13(3):429-39. doi: 10.1016/j.cld.2009.05.008. Clin Liver Dis. 2009. PMID: 19628159 Review.
Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
Njoroge FG, Chen KX, Shih NY, Piwinski JJ. Njoroge FG, et al. Acc Chem Res. 2008 Jan;41(1):50-9. doi: 10.1021/ar700109k. Acc Chem Res. 2008. PMID: 18193821 Review.
Potent ketoamide inhibitors of HCV NS3 protease derived from quaternized P1 groups.
Venkatraman S, Velazquez F, Wu W, Blackman M, Madison V, Njoroge FG. Venkatraman S, et al. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2151-5. doi: 10.1016/j.bmcl.2010.02.051. Epub 2010 Feb 14. Bioorg Med Chem Lett. 2010. PMID: 20226659
The introduction of P4 substituted 1-methylcyclohexyl groups into Boceprevir: a change in direction in the search for a second generation HCV NS3 protease inhibitor.
Bennett F, Huang Y, Hendrata S, Lovey R, Bogen SL, Pan W, Guo Z, Prongay A, Chen KX, Arasappan A, Venkatraman S, Velazquez F, Nair L, Sannigrahi M, Tong X, Pichardo J, Cheng KC, Girijavallabhan VM, Saksena AK, Njoroge FG. Bennett F, et al. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2617-21. doi: 10.1016/j.bmcl.2010.02.063. Epub 2010 Feb 19. Bioorg Med Chem Lett. 2010. PMID: 20303756
Hepatitis C virus resistance to protease inhibitors.
Halfon P, Locarnini S. Halfon P, et al. J Hepatol. 2011 Jul;55(1):192-206. doi: 10.1016/j.jhep.2011.01.011. Epub 2011 Feb 1. J Hepatol. 2011. PMID: 21284949 Review.

See all similar articles

Cited by

Molecular and Structural Basis for Cγ-C Bond Formation by PLP-Dependent Enzyme Fub7.
Liu S, Yeh C, Reavill C, Jones B, Zou Y, Hai Y. Liu S, et al. Angew Chem Int Ed Engl. 2024 Mar 22;63(13):e202317161. doi: 10.1002/anie.202317161. Epub 2024 Feb 20. Angew Chem Int Ed Engl. 2024. PMID: 38308582 Free PMC article.
Inhibition of Hepatitis E Virus Replication by Novel Inhibitor Targeting Methyltransferase.
Hooda P, Chaudhary M, Parvez MK, Sinha N, Sehgal D. Hooda P, et al. Viruses. 2022 Aug 15;14(8):1778. doi: 10.3390/v14081778. Viruses. 2022. PMID: 36016400 Free PMC article.
Identification and Characterization of Zika Virus NS5 Methyltransferase Inhibitors.
Song W, Zhang H, Zhang Y, Chen Y, Lin Y, Han Y, Jiang J. Song W, et al. Front Cell Infect Microbiol. 2021 Apr 7;11:665379. doi: 10.3389/fcimb.2021.665379. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33898335 Free PMC article.
Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical Characterization.
Shotwell JB, Baskaran S, Chong P, Creech KL, Crosby RM, Dickson H, Fang J, Garrido D, Mathis A, Maung J, Parks DJ, Pouliot JJ, Price DJ, Rai R, Seal JW 3rd, Schmitz U, Tai VW, Thomson M, Xie M, Xiong ZZ, Peat AJ. Shotwell JB, et al. ACS Med Chem Lett. 2012 May 24;3(7):565-9. doi: 10.1021/ml300090x. eCollection 2012 Jul 12. ACS Med Chem Lett. 2012. PMID: 24900511 Free PMC article.
Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.
Withers-Martinez C, Suarez C, Fulle S, Kher S, Penzo M, Ebejer JP, Koussis K, Hackett F, Jirgensons A, Finn P, Blackman MJ. Withers-Martinez C, et al. Int J Parasitol. 2012 May 15;42(6):597-612. doi: 10.1016/j.ijpara.2012.04.005. Epub 2012 Apr 27. Int J Parasitol. 2012. PMID: 22543039 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science